生物醫藥技術全國重點實驗室
（香港大學）
State Key Laboratory of Pharmaceutical Biotechnology
（The University of Hong Kong)
Field of Research
Biomarker discovery and multi-omics analyses in cardiometabolic disorders
Biography
Dr. Chloe Cheung earned her BSc in Human Genetics from University College London in 2006, followed by an MSc in Human Molecular Genetics from Imperial College London in 2007. She completed her PhD in Genetic Epidemiology in 2012 and an MPH in 2017, both at the University of Hong Kong. After completing her postdoctoral training in 2016, she was promoted to Research Assistant Professor in the Department of Medicine at the School of Clinical Medicine, University of Hong Kong.
Her research primarily focuses on identifying novel biomarkers for cardiometabolic diseases. Utilizing multi-omics platforms, she has successfully discovered genetic and circulating biomarkers associated with type 2 diabetes and its related complications. Dr. Cheung’s findings have been published in numerous international peer-reviewed journals, including Nature Communications, Diabetes Care, Diabetologia, Diabetes, Cardiovascular Diabetology, and Journal of Advanced Research.
Selected Publications
-
Cheung CYY, Wan P, Wan H, Xu C, Jia X, Fong CH, Lui DT, Song E, Chen X, Chow WS, Woo YC, Tan KC, Seto WK, Wang C, Shen J, Lam KS, Lee CH and Xu A. Development and clinical validation of a novel protein biomarkers-based algorithm for risk prediction and diagnosis of advanced liver fibrosis: a multi-centre study. (2025) J Adv Res. S2090-1232(25)00737-4.
-
Xu CX*, Cheung CYY*#, Zhong JD, Lin YF, Fong CHY, Jiang X, Jia X, Lui DTW, Lee CH, Lam KSL, and Xu A#. A five-plasma-protein-based algorithm for predicting incident chronic kidney disease in type 2 diabetes. (2025) JASN 37(4):790-800 (*Co-first; #Co-corresponding)
-
Su X*, Cheung CYY*, Zhong J, Ru Y, Fong CHY, Lee CH, Liu Y, Cheung CKY, Lam KSL, Xu A, Cai Z. Ten metabolites-based algorithm predicts the future development of type 2 diabetes in Chinese. (2023) J Adv Res. S2090-1232(23)00365-X. (*Co-first)
-
Zhong J*, Cheung CYY*, Su X*, Lee CH, Ru Y, Fong CHY, Liu Y, Cheung CKY, Lam KSL, Cai Z and Xu A. Specific triacylglycerol, diacylglycerol, and lyso-phosphatidylcholine species for the prediction of type 2 diabetes: a ~16-year prospective study in Chinese. (2022) Cardiovascular Diabetology. 21(1):234 (*Co-first)